Dana Vigier

Dana Vigier, MD, is a seasoned leader in the oncology and rare disease sectors, currently serving as the VP, Central and Northern Europe Area Head for Alexion, part of AstraZeneca. With prior roles including VP of the Oncology Business Unit at Bristol-Myers Squibb and leadership positions at AstraZeneca and GSK, Dana has garnered extensive experience in market access and commercial strategy. Their commitment to improving patient access to medical innovations is evident in their work leading diverse teams and negotiating complex market environments. Dana has a history of managing substantial sales and overseeing multiple countries, consistently striving to enhance healthcare outcomes for patients.